Tocqueville Asset Management’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Sell |
18,750
-300
| -2% | -$13K | 0.01% | 377 |
|
|
2025
Q1 | $659K | Buy |
19,050
+75
| +0.4% | +$2.59K | 0.01% | 379 |
|
|
2024
Q4 | $521K | Buy |
18,975
+1,275
| +7% | +$35K | 0.01% | 422 |
|
|
2024
Q3 | $451K | Buy |
17,700
+2,500
| +16% | +$63.7K | 0.01% | 419 |
|
|
2024
Q2 | $385K | Buy |
15,200
+2,500
| +20% | +$63.3K | 0.01% | 434 |
|
|
2024
Q1 | $393K | Sell |
12,700
-700
| -5% | -$21.6K | 0.01% | 435 |
|
|
2023
Q4 | $541K | Sell |
13,400
-800
| -6% | -$32.3K | 0.01% | 387 |
|
|
2023
Q3 | $374K | Sell |
14,200
-5,050
| -26% | -$133K | 0.01% | 423 |
|
|
2023
Q2 | $331K | Sell |
19,250
-2,800
| -13% | -$48.2K | 0.01% | 450 |
|
|
2023
Q1 | $366K | Buy |
+22,050
| New | +$366K | 0.01% | 436 |
|